Identification of CD161 expression as a novel prognostic biomarker in breast cancer correlated with immune infiltration
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.996345
Abstract: Background: CD161 has been identified as a prognostic biomarker in many neoplasms, but its role in breast cancer (BC) has not been fully explained. We aimed to investigate the molecular mechanism and prognostic value of… read more here.
Keywords: biomarker; immune infiltration; expression; cd161 ... See more keywords